Coronary Plaque Characteristics Affect No-Reflow During Primary Percutaneous Coronary Intervention: A Pooled Analysis

Bu-Chun Zhang, Cheng Wang, Zhi-Wen Zhou

  • 1Department of Cardiology, The Affiliated Hospital of Xuzhou Medical College, Jiangsu 221002, China; Department of Cardiology, Shanghai Xuhui Central Hospital, Shanghai, China.

Insights

Percutaneous coronary intervention (PCI) no-reflow is linked to higher fibrofatty plaque volume and larger plaque area. Intravascular ultrasound (IVUS) data show specific plaque characteristics predict no-reflow, aiding intervention strategies.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Imaging

Background:

  • The no-reflow phenomenon complicates percutaneous coronary intervention (PCI).
  • Coronary plaque composition's role in no-reflow remains debated.
  • Intravascular ultrasound (IVUS) provides detailed plaque imaging.

Purpose of the Study:

  • To systematically evaluate the association between coronary plaque characteristics and no-reflow after PCI.
  • To synthesize evidence from IVUS studies using meta-analysis.

Main Methods:

  • Systematic literature search of MEDLINE, Embase, Cochrane, and Ovid.
  • Meta-analysis of 14 observational trials including 1457 patients.
  • Analysis of plaque composition and arterial remodeling parameters detected by IVUS.

Main Results:

  • No-reflow group showed significantly higher absolute volumes of fibrofatty plaque, external elastic membrane cross-sectional area (EEM-CSA), and plaque area.
  • Higher artery remodeling index was observed in the no-reflow group.
  • A significantly smaller percentage of fibrous plaque was found in patients experiencing no-reflow.

Conclusions:

  • High absolute volume of fibrofatty plaque, EEM-CSA, plaque area, and artery remodeling index are associated with no-reflow post-PCI.
  • A decreased percentage of fibrous plaque is a predictor of no-reflow.
  • IVUS-detected plaque characteristics in culprit lesions can help predict no-reflow development.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
970
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
727
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.7K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
410
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
440